SAN DIEGO & SINGAPORE, Dec 22 (Bernama-BUSINESS WIRE) — ImmunoScape, a biotechnology company focused on next-generation T Cell receptor (TCR)-based immunotherapies, announced a partnership with the Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development hosted by the Agency for Science, Technology and Research (A*STAR).
This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20231221788895/en/